Global Neurology Academy

Diagnosing Myasthenia Gravis: The Impact of Social Media
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's Roundtable
Diagnosing Myasthenia Gravis: The Impact of Social Media
- Ashley Baker, MSN, PMHNP
- Vishnu Pandurangadu, MD/MBA, FACEP
- Pritikanta Paul, MD
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiers
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiers
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Unraveling Schizophrenia: Neurobiological and Genetic Factors to Consider
Unraveling Schizophrenia: Neurobiological and Genetic Factors to Consider
NeuroFrontiers
Unraveling Schizophrenia: Neurobiological and Genetic Factors to Consider
- Ashley Baker, MSN, PMHNP
- Greg Mattingly, MD
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
NeuroFrontiers
Personalizing Care Plans for Schizophrenia Patients: Key Factors to Consider
- Ashley Baker, MSN, PMHNP
- Desiree Matthews, PMHNP-BC
- Rakesh Jain, MD, MPH
Long-Term Management of Schizophrenia: Preventing Relapse and Promoting Recovery
Long-Term Management of Schizophrenia: Preventing Relapse and Promoting Recovery
NeuroFrontiers
Long-Term Management of Schizophrenia: Preventing Relapse and Promoting Recovery
- Ashley Baker, MSN, PMHNP
- Rakesh Jain, MD, MPH
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
NeuroFrontiers
Comprehensive Care: Navigating Neurobehavioral Issues in DMD Patients
- John F. Brandsema, MD
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
NeuroFrontiers
Researching the Overlap: Hepatic Encephalopathy and Dementia in Focus
- Charles Turck, PharmD, BCPS, BCCCP
- Jasmohan Bajaj, MD

Medical News

Medical News
Novel Gene Therapy Shows Promise for Treating IgA Nephropathy, Purespring Therapeutics Reports
biospace.com
11/06/2024
Read more
Medical News
Aerobic Exercise During Chemotherapy May Improve Cognitive Function in Breast Cancer Patients
miragenews.com
11/05/2024
Read more
Medical News
Childhood Neglect Linked to Increased Risk of Stroke, COPD, and Depression in Adulthood
medicalxpress.com
11/05/2024
Read more
Medical News
AI-Driven Tool Flags High Heart Failure Risk in Diabetic Patients
utsouthwestern.edu
11/04/2024
Read more

See more news

CME/CE

Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
CME/CE
Case Concepts in Generalized Myasthenia Gravis: Balancing the Need for Glucocorticoids and Integrating FcRn Inhibitors Into Treatment Plans
1.00 credit
- Michael Erdman, PharmD, BCCCP
- Ali A. Habib, MD
1.00 credit
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
CME/CE
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
1.00 credit
- Perry Shieh, MD, PhD
1.00 credit
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
CME/CE
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
1.00 credit
- Craig M. McDonald, MD
- Crystal Proud, MD
- Aravindhan Veerapandiyan, MD
1.00 credit
Diagnosing ATTRv-PN: What's in Your Toolbox?
Diagnosing ATTRv-PN: What's in Your Toolbox?
MinuteCE®
Diagnosing ATTRv-PN: What's in Your Toolbox?
1.00 program credit
- Sami Khella, MD
1.00 program credit

Clinical Practice

The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
NeuroFrontiers
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
- John A. Morren, MD, FAAN, FAANEM
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
NeuroFrontiers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
NeuroFrontiers
Advances in DMD Care: Evaluating a Gene Therapy’s Efficacy and Safety
- Charles Turck, PharmD, BCPS, BCCCP
- John F. Brandsema, MD
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
NeuroFrontiers
How DDL-920 Could Help Restore Cognitive Function in Alzheimer's Patients
- Ashley Baker, MSN, PMHNP
- Istvan Mody, PhD

Programs

Continuum of Care: Managing DMD in Pediatric and Adult Patients
Continuum of Care: Managing DMD in Pediatric and Adult Patients
NeuroFrontiers
Continuum of Care: Managing DMD in Pediatric and Adult Patients
- John F. Brandsema, MD
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
NeuroFrontiers
The Impact of a Cholesterol-Lowering Medication on Alzheimer's Disease
- Charles Turck, PharmD, BCPS, BCCCP
- Dr. Robert J. Shmookler Reis, PhD
- Dr. Srinivas Ayyadevara, PhD
Public Health Disparities in Alzheimer's Disease and Brain Health
Public Health Disparities in Alzheimer's Disease and Brain Health
NeuroFrontiers
Public Health Disparities in Alzheimer's Disease and Brain Health
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
NeuroFrontiers
Managing NF1 PN with this First and Only FDA-Approved Treatment Option
- Sandy Millman
- Pinki Prasad, MD